All terms in BMONT

Label Id Description
cholesterol CHEBI_16113 [A cholestanoid consisting of cholestane having a double bond at the 5,6-position as well as a 3beta-hydroxy group.]
bipolar disorder DOID_3312 [A mood disorder that involves alternating periods of mania and depression.]
cortical thickness EFO_0004840 [Is a quantification of the thickness of brain cortex, e.g. measured by MRI, used in the diagnosis of Alzheimer's disease and other neurological conditions]
Pupillometry NCIT_C120540 [A technique used to measure the diameter of the pupil in response to stimuli.]
galactomannan CHEBI_27680 [A heteroglycan consisting of a mannan backbone with galactose side groups.]
Diet Therapy OMIT_0005305 [Adjusting the quantity and quality of food intake to improve health status of an individual. This term does not include the methods of food intake (NUTRITIONAL SUPPORT).]
Smartphone NCIT_C175504 [A mobile cellular telephone that has an integrated computer with an operating system capable of web browsing and running downloaded applications. Smartphones typically have touchscreen interfaces, video calling capabilities, and other advanced built-in features and applications.]
brain-derived neurotrophic factor PR_000004716 [A neurotrophin that is a translation product of the human BDNF gene or a 1:1 ortholog thereof.]
urine UBERON_0001088 [Excretion that is the output of a kidney.]
Diffusion Kurtosis Imaging NCIT_C116487 [An extension of conventional diffusion tension imaging, which estimates the kurtosis of the water diffusion probability distribution function. This technique is most commonly used to study the brain.]
knee extension strength BMONT_0000134 [Knee extension strength refers to the amount of force that the muscles on the front of the thigh—primarily the quadriceps—can generate to straighten (extend) the knee joint.]
biomarker of aging text mining bin BMONT_0000136 [A placeholder for aging biomarkers, organized based on the reasoning application 'isBiomarkerOfAging some disease', to facilitate text mining and information retrieval for aging research.]
Clinical Endpoint NCIT_C68771 [A characteristic or variable that reflects how a patient feels, functions, or survives. Clinical endpoints are distinct measurements or analyses of disease characteristics observed in a study or a clinical trial that reflect the effect of a therapeutic intervention. Clinical endpoints are the most credible characteristics used in the assessment of the benefits and risks of a therapeutic intervention in randomized clinical trials.]
disease course OGMS_0000063 [The totality of all processes through which a given disease instance is realized.]
pulmonary arterial hypertension EFO_0001361 [Pulmonary arterial hypertension (PAH) is a group of diseases characterized by mean pulmonary artery pressure >20 mmHg and elevated pulmonary arterial resistance leading to right heart failure. PAH is progressive and potentially fatal. PAH may be idiopathic and/ or familial, have overt features of venous/capillary involvement (pulmonary veno-occlusive disease, PVOD/pulmonary capillary hemangiomatosis, PCH), induced by drug or toxin (drug-or toxin-induced PAH), or associated with other diseases like congenital heart disease, connective tissue disease, HIV, schistosomiasis, portal hypertension (PAH associated with other disease)., A syndrome with pathological changes in the pulmonary arteries and impaired PULMONARY CIRCULATION that can be the result of PULMONARY HYPERTENSION. Ayerza syndrome is characterized by slowly developing ASTHMA; BRONCHITIS; DYSPNEA; and CYANOSIS in association with POLYCYTHEMIA., Increased VASCULAR RESISTANCE in the PULMONARY CIRCULATION, usually secondary to HEART DISEASES or LUNG DISEASES.]
inflammatory biomarker measurement EFO_0004872 [Is a quantification of any molecule involved in the process of inflammatory response.]
blood glucose level CMO_0000046 [Measurement of the amount of glucose, the monosaccharide sugar, C6H12O6, occurring widely in plant and animal tissues which is one of the three dietary monosaccharides that are absorbed directly into the bloodstream during digestion, is the end product of carbohydrate metabolism, and is the chief source of energy for living organisms, in a specified volume of blood, the fluid that circulates through the heart, arteries, capillaries and veins carrying nutrients and oxygen to the body tissues and metabolites away from them.]
weight loss SYMP_0000178 [A weight symptom that is characterized by a reduction of the total body mass, by a mean loss of fluid, body fat (adipose tissue), or lean mass (namely bone mineral deposits, muscle, tendon, and other connective tissue). Weight loss can either occur unintentionally because of malnourishment or an underlying disease.]
biopsy OBI_0002650 [A specimen collection that obtains a sample of tissue or cell from a living multicellular organism body for diagnostic purposes by means intended to be minimally invasive.]
European Medicines Agency NCIT_C142543 [A public health agency based in London that is responsible for the scientific evaluation, supervision, and safety monitoring of medicines in the European Union.]